Sweet CS - Search Results

1

Design and discovery in the development of long-acting renin inhibitors.

Veber DF, Payne LS, Williams PD, Perlow DS, Lundell GF, Gould NP, Siegl PK, Sweet CS, Freidinger RM. Veber DF, et al. Among authors: sweet cs. Biochem Soc Trans. 1990 Dec;18(6):1291-4. doi: 10.1042/bst0181291. Biochem Soc Trans. 1990. PMID: 2088926 No abstract available.

2

In vivo pharmacology of L-158,809, a new highly potent and selective nonpeptide angiotensin II receptor antagonist.

Siegl PK, Chang RS, Mantlo NB, Chakravarty PK, Ondeyka DL, Greenlee WJ, Patchett AA, Sweet CS, Lotti VJ. Siegl PK, et al. Among authors: sweet cs. J Pharmacol Exp Ther. 1992 Jul;262(1):139-44. J Pharmacol Exp Ther. 1992. PMID: 1625193

3

Potent, orally active imidazo[4,5-b]pyridine-based angiotensin II receptor antagonists.

Mantlo NB, Chakravarty PK, Ondeyka DL, Siegl PK, Chang RS, Lotti VJ, Faust KA, Chen TB, Schorn TW, Sweet CS, et al. Mantlo NB, et al. Among authors: sweet cs. J Med Chem. 1991 Sep;34(9):2919-22. doi: 10.1021/jm00113a035. J Med Chem. 1991. PMID: 1895308 No abstract available.

4

Symbiotic approach to drug design: antihypertensive beta-adrenergic blocking agents.

Baldwin JJ, Lumma WC Jr, Lundell GF, Ponticello GS, Raab AW, Engelhardt EL, Hirschmann R, Sweet CS, Scriabine A. Baldwin JJ, et al. Among authors: sweet cs. J Med Chem. 1979 Nov;22(11):1284-90. doi: 10.1021/jm00197a002. J Med Chem. 1979. PMID: 42797 No abstract available.

5

Responses to amrinone in isolated cardiac muscles from cat, rabbit, and guinea pig.

Siegl PK, Morgan G, Sweet CS. Siegl PK, et al. Among authors: sweet cs. J Cardiovasc Pharmacol. 1984 Mar-Apr;6(2):281-7. doi: 10.1097/00005344-198403000-00012. J Cardiovasc Pharmacol. 1984. PMID: 6200717

6

Comparison of cardiovascular responses to the bradycardic drugs, alinidine, AQ-A 39, and mixidine, in the anesthetized dog.

Siegl PK, Wenger HC, Sweet CS. Siegl PK, et al. Among authors: sweet cs. J Cardiovasc Pharmacol. 1984 Jul-Aug;6(4):565-74. doi: 10.1097/00005344-198407000-00003. J Cardiovasc Pharmacol. 1984. PMID: 6206308

7

beta-Adrenergic blocking agents with acute antihypertensive activity.

Baldwin JJ, Engelhardt EL, Hirschmann R, Lundell GF, Ponticello GS, Ludden CT, Sweet CS, Scriabine A, Share NN, Hall R. Baldwin JJ, et al. Among authors: sweet cs. J Med Chem. 1979 Jun;22(6):687-94. doi: 10.1021/jm00192a015. J Med Chem. 1979. PMID: 37337

8

Antihypertensive beta-adrenergic blocking agents: N-aralkyl analogues of 2-[3-(tert-butylamino)-2-hydroxypropoxy]-3-cyanopyridine.

McClure DE, Baldwin JJ, Randall WC, Lyon TF, Mensler K, Lundell GF, Raab AW, Gross D, Risley EA, Sweet CS, Williams M. McClure DE, et al. Among authors: sweet cs. J Med Chem. 1983 May;26(5):649-57. doi: 10.1021/jm00359a006. J Med Chem. 1983. PMID: 6132999

9

Issues surrounding a local cardiac renin system and the beneficial actions of angiotensin-converting enzyme inhibitors in ischemic myocardium.

Sweet CS. Sweet CS. Am J Cardiol. 1990 May 22;65(19):11I-13I. doi: 10.1016/0002-9149(90)90119-l. Am J Cardiol. 1990. PMID: 2186609 Review.

10

How well have animal studies with losartan predicted responses in humans?

Sweet CS, Nelson EB. Sweet CS, et al. J Hypertens Suppl. 1993 Apr;11(3):S63-7. J Hypertens Suppl. 1993. PMID: 8315522 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

92 results

Search Page

Filters